WAVE Life Sciences (WVE) – Analyst Comments
-
RBC Capital on WAVE Life Sciences (WVE): 'We appreciate the progress but remain cautious'
-
Raymond James Starts WAVE Life Sciences (WVE) at Outperform, 'we expect WVE-006 (in AATD) and WVE-N531 (in DMD) to work and drive upside'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to WVE Stock Lookup